Share this article

Facebook
Twitter
Print
Email

Lupin recieved EIR from USFDA for its Nagpur facility

lupin-pharmaceuticals-office

Drug firm Lupin on Monday said it has received an establishment inspection report (EIR) from the US health regulator post the inspection of its Nagpur facility. “The United States Food and Drug Administration (USFDA) conducted a pre-approval inspection for its Phenytoin Sodium Extended Release 100 mg capsules,” Lupin said in a filing to BSE.

The plant was inspected by USFDA in September 2018, the company added.

USFDA gives EIR on closure of inspection of an establishment that is the subject of an FDA or FDA-contracted inspection.

Commenting on the development, Lupin MD Nilesh Gupta said: “The successful completion of the Nagpur facility inspection is a positive development as we continue our journey to meet and exceed international regulatory standards.

RECENT NEWS

Jet Airways Chairman Naresh Goyal to Invest Up to Rs 700 Crore in Jet Airways

Jet Airways chairman Naresh Goyal is ready to invest up to Rs 700 crore in Jet Airways on the condition that his stake does not fall below 25%. Goyal’s offer comes against the backdrop of strategic partner Etihad reportedly putting forward strict conditions, including that Goyal should give up control, for infusing funds into the crisis-hit carrier.

Bihar CM Nitish Kumar Ready to Reconcile with RJD

Bihar Chief Minister Nitish Kumar on Tuesday night claimed that he has “lots of love” for Rashtriya Janata Dal (RJD) leader Tejashwi Yadav despite the “harsh words” the latter often uses.

PM Modi Lashes Out At Kerala Government for Sabarimala Mismanagement

In Kollam today for the launch of two projects, PM Modi said: “The CPM government’s conduct on Sabarimala will go down in history as the most shameful action of any government in power… We know CPM government never respected spirituality, religion… but no one thought it would turn so shameful”.

Spat Over Rafale Is On High Gear

In its response to Pune-based activist Vihar Durve who had sought the report from CAG, the country’s auditor said, “The audit is under progress and the report is yet to be finalised. The information cannot be given under Section 8(1)(C) of the RTI Act as the disclosure would cause breach of Parliament”.